STAT November 19, 2024
Andrew Joseph

Pharma executives at an investor conference minimized the potential impact of RFK Jr. at HHS

LONDON — Robert F. Kennedy Jr. has been a vocal critic of the pharma industry. He’s said it’s corrupted U.S. health agencies and has attacked, often with false arguments, products from vaccines to obesity medications.

So when President-elect Trump, who...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Govt Agencies, HHS, Pharma, Pharma / Biotech, Trends
4 top healthcare CIOs: Forbes
Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development
53% of US adults are eligible for Ozempic, Wegovy: Study
The Athlete's Edge: How One Biotech Startup Is Mining Elite Athletes' Gut Bacteria To Create Next-Gen Probiotics
Eli Lilly drug cuts genetic form of cholesterol by 86%: Study

Share This Article